App-Quantinova.ai

LIFE IS A RODEO - STROKE AFTER MECHANICAL BULL RIDING

Brian Henstenburg - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

LEFT VENTRICULAR NONCOMPACTION: ISOLATED OR ASSOCIATED?

Najah Khan - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular noncompaction

Hydroxychloroquine

ARTERIAL THROMBOSIS IN COVID 19 AND ANTIPHOSPHOLIPID ANTIBODIES

Eiman Elhouderi - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Antiphospholipid syndrome

Hydroxychloroquine

Data partitioning from the two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience

Giulia Maria Stella - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Lymphocytopenia

Hydroxychloroquine

Progressive fibrosis is common in patients with Sjögrens syndrome and Interstitial lung disease

Caroline Diou - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Sjogren's syndrome

Hydroxychloroquine

Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection

Peter Kamstrup - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Azithromycin and Hydroxychloroquine in hospitalized patients with confirmed SARS-CoV-2 infection - a randomized placebo-controlled trial (ProPAC-COVID Trial)

Pradeesh Sivapalan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

Non-PTH Mediated Hypercalcemia in a Patient with Newly Diagnosed Lupus on Dialysis

Brian Jones - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Hypercalcaemia

Hydroxychloroquine

Kidney Failure and Common Variable Immunodeficiency: an Unusual Presentation

Remy Fadel - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Common variable immunodeficiency

Hydroxychloroquine

A single-arm, phase II study of autophagy modulation using hydroxychloroquine in addition to encorafenib and cetuximab or panitumumab in metastatic BRAF-mutated colorectal cancer refractory to standard therapy.

Chetan Vakkalagadda - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2023

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Hereditary pancreatitis

Hydroxychloroquine

Cell-free fetal DNA impairs trophoblast migration in a TLR9-dependent manner and is reversed by hydroxychloroquine

Daisy Leon-Martinez - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Effectiveness of low-dose hydroxychloroquine versus placebo for the prevention of severe pneumonia in pregnant women with SARS-CoV2 infection: PROTOCOL for a randomised controlled trial (HYPREG trial)

J. Torres-Torres - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Congenital complete atrioventricular block: two cases with different outcomes

F.C. Cordeiro - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Atrioventricular septal defect

Hydroxychloroquine

Improved uterine artery perfusion in normal outcome pregnancies with antiphospholipid antibody syndrome under treatment: a matched longitudinal study

V. Canti - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

Hydroxychloroquine

Prenatal diagnosis of fetal autoimmune atrioventricular block

H. Sut - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Tricuspid regurgitation

Hydroxychloroquine

Hydroxychloroquine-related adverse events, attrition and reasons for cessation over 5 years at a district general hospital: estimating future ophthalmology screening service use

Dalal Barahman - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Hydroxychloroquine retinopathy incidence in a UK specialist centre: a machine learning/natural language processing pilot study

Yasser Mushtaq - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Diabetic retinopathy

Hydroxychloroquine

Erosive psoriatic arthritis causing deafness

Alice K Coulton - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Raynaud syndrome

Hydroxychloroquine

Effect of upadacitinib in a patient with primary Sjogren syndrome: a case report

Muhammad Shoaib Momen Majumder - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Sjogren's syndrome

Hydroxychloroquine

Hypertrophic pulmonary osteoarthropathy, rheumatoid arthritis mimic: don’t distract with immunology

Abdul B Awan - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Inflammatory Arthritis

Hydroxychloroquine

Filters

1151 Abstracts